Related Experiment Videos
[Left ventricular insufficiency: systolic versus diastolic dysfunction]
M Federmann1, B Risti, O M Hess
1Departement für Innere Medizin, Kardiologie, Universitätsspital Zürich.
Schweizerische Medizinische Wochenschrift
|July 2, 1994
Summary
Left ventricular failure presents as systolic dysfunction (poor prognosis) or diastolic dysfunction (better prognosis). Treatments differ, with ACE-inhibitors for systolic and calcium channel blockers for diastolic dysfunction.
Area of Science:
- Cardiology
- Internal Medicine
- Heart Failure Pathophysiology
Background:
- Left ventricular failure is categorized into systolic pump failure (systolic dysfunction) and diastolic filling failure (diastolic dysfunction).
- Understanding the distinct clinical patterns and prognoses of these conditions is crucial for effective heart failure management.
Observation:
- Systolic dysfunction is characterized by left ventricular failure, cardiomegaly, and reduced ejection fraction.
- Diastolic dysfunction presents with pulmonary congestion, a normal or mildly enlarged ventricle, and preserved ejection fraction.
Findings:
- Systolic dysfunction has a poorer prognosis (40% 5-year survival) compared to isolated diastolic dysfunction (70% 5-year survival).
- Treatment for systolic dysfunction involves ACE-inhibitors, diuretics, digitalis, low-dose beta-blockers, and spironolactone.
- Diastolic dysfunction management prioritizes calcium channel blockers for improved relaxation and filling, with ACE-inhibitors for hypertensive heart disease; diuretics and beta-blockers are second-line, and digitalis is contraindicated.
Implications:
- Differentiating between systolic and diastolic dysfunction is essential for tailoring appropriate medical interventions.
- Targeted pharmacotherapy based on the type of ventricular dysfunction can significantly improve patient outcomes and survival rates.
- Further research into optimizing treatment strategies for both forms of left ventricular failure is warranted.